Human Trial Results Show Excellent Safety Data, Positive Immune Responses From GeoVax's DNA/MVA AIDS Vaccines

Tue, 06 Feb 2007 02:00 PM EST

... GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biotechnology company, today reported successful early results from two ongoing AIDS prevention Phase I human vaccine trials. Results from the first low dose trial indicate a good safety profile as well as positive immune responses in human volunteers receiving 1/10th dose of GeoVax's AIDS vaccine. [click link for full article] ...